药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bimatoprost
Deferasirox
The risk or severity of gastrointestinal bleeding can be increased when Acenocoumarol is combined with Deferasirox.
Bimatoprost
Dabigatran etexilate
Dabigatran etexilate may increase the anticoagulant activities of Acenocoumarol.
Bimatoprost
Apixaban
Apixaban may increase the anticoagulant activities of Acenocoumarol.
Ondansetron
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceftibuten.
Ondansetron
Neomycin
The risk or severity of nephrotoxicity can be increased when Neomycin is combined with Ceftibuten.
Ondansetron
Polymyxin B
The risk or severity of adverse effects can be increased when Ceftibuten is combined with Polymyxin B.
Ondansetron
Reviparin
The therapeutic efficacy of Reviparin can be decreased when used in combination with Ceftibuten.
Ondansetron
Edetic acid
The therapeutic efficacy of Edetic acid can be decreased when used in combination with Ceftibuten.
Ondansetron
Troxerutin
The therapeutic efficacy of Troxerutin can be decreased when used in combination with Ceftibuten.
Ondansetron
Dabigatran
The therapeutic efficacy of Dabigatran can be decreased when used in combination with Ceftibuten.
Ondansetron
Edetate calcium disodium anhydrous
The therapeutic efficacy of Edetate calcium disodium anhydrous can be decreased when used in combination with Ceftibuten.
Ondansetron
Tocopherylquinone
The therapeutic efficacy of Tocopherylquinone can be decreased when used in combination with Ceftibuten.
Ondansetron
Saruplase
The therapeutic efficacy of Saruplase can be decreased when used in combination with Ceftibuten.
Ondansetron
Melagatran
The therapeutic efficacy of Melagatran can be decreased when used in combination with Ceftibuten.
Ondansetron
Brinase
The therapeutic efficacy of Brinase can be decreased when used in combination with Ceftibuten.
Ondansetron
Protein S human
The therapeutic efficacy of Protein S human can be decreased when used in combination with Ceftibuten.
Ondansetron
Gabexate
The therapeutic efficacy of Gabexate can be decreased when used in combination with Ceftibuten.
Ondansetron
Monteplase
The therapeutic efficacy of Monteplase can be decreased when used in combination with Ceftibuten.
Ondansetron
Nafamostat
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftibuten.
Ondansetron
Betrixaban
The therapeutic efficacy of Betrixaban can be decreased when used in combination with Ceftibuten.